News
XRAY
26.41
-0.08%
-0.02
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Miss Estimates
NASDAQ · 1d ago
Dentsply Sirona Is Maintained at Neutral by Baird
Dow Jones · 4d ago
Dentsply Sirona Price Target Cut to $31.00/Share From $33.00 by Baird
Dow Jones · 4d ago
Weekly Report: what happened at XRAY last week (0715-0719)?
Weekly Report · 4d ago
Dentsply Sirona Is Maintained at Hold by Stifel
Dow Jones · 07/18 15:06
Dentsply Sirona Price Target Cut to $28.00/Share From $30.00 by Stifel
Dow Jones · 07/18 15:06
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analysts
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. The company has an average 12-month price target of $32.5. 10 analysts have released ratings for the company in the last three months. The average price target is 9.22% lower than the prior average of $35.80.
Benzinga · 07/18 15:01
Stifel Maintains Hold on Dentsply Sirona, Lowers Price Target to $28
Benzinga · 07/18 14:55
DENTSPLY SIRONA INC <XRAY.O>: STIFEL CUTS TARGET PRICE TO $28 FROM $30
Reuters · 07/18 11:04
Weekly Report: what happened at XRAY last week (0708-0712)?
Weekly Report · 07/15 09:07
Morgan Stanley Remains a Buy on DENTSPLY SIRONA (XRAY)
TipRanks · 07/12 12:26
U.S. RESEARCH ROUNDUP-Boston Beer Company, Inter Parfums, Netflix
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Boston Beer Company, Inter Parfums and Netflix among those with revised targets. Analysts also raise their targets on Adobe, Amgen and other companies. The companies are all listed on the Nasdaq.
Reuters · 07/12 07:46
Dentsply Sirona On Track for Largest Percent Increase Since February 2023 -- Data Talk
Dow Jones · 07/11 18:53
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes
DENTSPLY SIRONA (NASDAQ:XRAY) has a Return on Capital Employed of 4.9%. The Medical Equipment industry average is 10%. We don't think the company has the makings of a multi-bagger. The company is applying 25% less capital to its business than it did five years ago. This is not a good sign for a company.
Simply Wall St · 07/11 13:59
Dentsply Sirona Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 07/09 15:27
Dentsply Sirona Price Target Cut to $27.00/Share From $28.00 by Evercore ISI Group
Dow Jones · 07/09 15:27
Evercore ISI Group Maintains Outperform on Dentsply Sirona, Lowers Price Target to $27
Benzinga · 07/09 15:16
U.S. RESEARCH ROUNDUP-Alphabet, Domino's Pizza, McKesson
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Alphabet, Domino's Pizza and McKesson among those with revised targets. Analysts raise target prices on several companies, including Apple, Amazon and Amazon.com. Others cut their targets on the same day.
Reuters · 07/09 06:49
Analysts See 15% Gains Ahead For IVOV
NASDAQ · 07/08 14:20
Dentsply Sirona Is Maintained at Outperform by Barrington Research
Dow Jones · 07/08 14:06
More
Webull provides a variety of real-time XRAY stock news. You can receive the latest news about Dentsply Sirona Inc through multiple platforms. This information may help you make smarter investment decisions.
About XRAY
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.